# #83 – Bill Harris, Ph.D.: Omega-3 fatty acids

**Channel:** Peter Attia MD
**Upload Date:** 2020-01-14
**URL:** https://www.youtube.com/watch?v=2Nz7nFlvx9M
**Duration:** 122 minutes

## Description

Original release date: 12/9/19

In this episode, Bill Harris, Ph.D. in human nutrition and expert on omega-3 fatty acids, sets the table by clearly defining the families of fatty acids (saturated, monounsaturated, polyunsaturated) before diving into the current landscape of polyunsaturated fat (omega-6 and omega-3) with a particular focus on EPA and DHA (the two main elements of fish oil supplements). Bill gives a historical overview, updates us on the latest science related to the health benefits, and provides plenty of insights as to how we should think about increasing our EPA and DHA intake.

We discuss:
-Bill’s long history of studying fatty acids [6:30];
-Defining the fatty acids—SFA, MUFA, PUFA, omega-3, omega-6, and more [9:45];
-What is the significance of fatty acids? Why should we care? [19:45];
-History of fat phobia, saturated fat, and does PUFA reduce cholesterol? [23:45];
-Breaking down the conversion process of omega-6 and omega-3 fatty acids including how we get to EPA and DHA [28:00]; 
-Takeaway from Bill’s 1980 study looking at how salmon oil affected cholesterol and triglyceride levels [36:15];
-History of our understanding of omega-3 and its effect on LDL cholesterol [45:00];
-Prescribed fish oil drugs vs. OTC supplements—Differences and recommended brands [52:00];
-Health benefits of EPA [57:45];
-Potential benefits of ALA and how it compares to taking EPA and DHA directly [1:12:45];
-Health benefits of DHA [1:17:15];
-Cell membrane omega-3 index—What is it, the role of genetics, how to increase it, and a recommended target [1:19:00];
-Is EPA or DHA neuroprotective? Can it help with depression? [1:23:30];
-Recommended fish to eat for EPA and DHA – Any mercury concerns? [1:25:45];
-Can omega-3 mitigate risks associated with smoking? [1:29:15];
-The problem with the omega-6 to omega-3 ratio [1:30:00];
-The problem with labeling any kind of fatty acid as “bad” [1:36:00];
-Why increasing EPA and DHA intake matters more than reducing omega-6 intake [1:38:00];
-Important takeaway from the VITAL study [1:46:30];
-Importance of testing your omega-3 index [1:53:00];
-Exciting study coming out soon, and why you need to take your fish oil with food [1:57:15]; and
-More.

Show notes page: https://peterattiamd.com/billharris/

--------
About:

The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more.

Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life).

Learn more: https://peterattiamd.com
Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe
Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

## AI Summary

Here's my comprehensive analysis of this episode of The Drive podcast with Bill Harris:

1. **Executive Summary**:
This episode features Dr. Bill Harris, an internationally recognized expert on omega-3 fatty acids, discussing the science behind fatty acids and their health implications. The conversation covers the chemical structure of different fats, their metabolism, and clinical significance, with particular focus on EPA and DHA. Key highlights include discussion of the REDUCE-IT trial and the evolution of our understanding of omega-3 benefits over the past 40 years.

2. **Key Medical/Scientific Points**:
- EPA and DHA are converted at less than 1% efficiency from ALA [1:12:15]
- Red blood cell EPA/DHA levels correlate well with other tissue levels except brain [1:14:28]
- Average American consumes 150-250mg combined EPA/DHA daily [1:38:16]
- It takes about 4 months to reach new steady state omega-3 levels after dietary changes [1:57:29]
- Optimal omega-3 index range is 8-12% in red blood cells [1:23:07]

3. **Health Optimization Tips**:
Universal Recommendations:
- Consider measuring omega-3 status via blood testing [1:54:36]
- Focus on increasing EPA/DHA rather than reducing omega-6 [1:43:47]

Context-specific:
- Take omega-3 supplements with food for better absorption [1:58:01]
- For high triglycerides, higher doses (4g) may be beneficial [1:54:04]

4. **Supplements & Medications**:
- Vascepa (pure EPA) - 4g daily in REDUCE-IT trial [1:00:48]
- Lovaza - 850mg EPA/DHA per capsule [1:54:04]
- Ethyl ester forms require food for absorption [1:58:01]

5. **Biomarkers & Testing**:
- Omega-3 Index (RBC EPA+DHA) optimal range: 8-12% [1:23:07]
- Takes 4 months to reach steady state after changes [1:57:29]
- Red blood cell levels correlate well with most tissues [1:14:28]

6. **Notable Quotes**:
"The problem is the lack of EPA and DHA. If you get those up, your arachidonic levels will go down." [1:43:47]

7. **Follow-up Questions**:
- What will be the results of the STRENGTH trial with EPA+DHA?
- Are there specific populations who might benefit more from EPA vs DHA?
- What is the optimal timing of omega-3 supplementation for those practicing time-restricted feeding?

This episode provides an excellent foundation for understanding fatty acid metabolism and supplementation strategies. The discussion of recent clinical trials and practical supplementation advice makes it particularly valuable for both clinicians and health-conscious individuals.
